World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
13800
World Ranking
14870
National Ranking
6224

Mark J. Pettenati publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark J. Pettenati sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 219 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mark J. Pettenati D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark J. Pettenati sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 55 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mark J. Pettenati is affiliated with Wake Forest University in the United States and has contributed extensively to research in medicine, biochemistry, genetics, and molecular biology. Their work spans multiple subfields including hematology, genetics, reproductive medicine, molecular biology, and public health, environmental and occupational health.

The research topics covered by Pettenati include:

  • Sperm and Testicular Function
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Reproductive Biology and Fertility
  • Sexual Differentiation and Disorders
  • Renal and related cancers

Some recent publications authored or coauthored by Pettenati are:

  • In Vitro Generation of Haploid Germ Cells from Human XY and XXY Immature Testes in a 3D Organoid System, 2024, Bioengineering
  • In vitro propagation of XXY human Klinefelter spermatogonial stem cells: A step towards new fertility opportunities, 2022, Frontiers in Endocrinology
  • In Vitro Propagation of XXY Undifferentiated Mouse Spermatogonia: Model for Fertility Preservation in Klinefelter Syndrome Patients, 2021, International Journal of Molecular Sciences
  • PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia, 2020, Case Reports in Hematology
  • Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion, 2020, Case Reports in Hematology

Pettenati frequently publishes in venues including:

  • Case Reports in Hematology
  • Frontiers in Endocrinology
  • Bioengineering
  • International Journal of Molecular Sciences
  • American Journal of Forensic Medicine & Pathology

Collaborations with other researchers are common in Pettenati's work. Frequent coauthors include:

  • Anthony Atala
  • Hooman Sadri-Ardekani
  • Guillermo Galdon
  • Nicholas A. Deebel
  • Nima Pourhabibi Zarandi

The research focus reflects a strong involvement in the understanding and treatment of hematological malignancies such as chronic and acute myeloid leukemia, alongside investigations into fertility preservation and reproductive biology related to chromosomal abnormalities like Klinefelter syndrome.

Best Publications

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Frequency of Prolonged Remission Duration after High-Dose Cytarabine Intensification in Acute Myeloid Leukemia Varies by Cytogenetic Subtype

    Clara D. Bloomfield;David Lawrence;John C. Byrd;Andrew Carroll

  • Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

    Krzysztof Mrózek;Guido Marcucci;Deedra Nicolet;Kati S. Maharry

  • Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

    Guido Marcucci;Krzysztof Mrózek;Amy S. Ruppert;Kati Maharry

  • The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies

    Jan O. Korbel;Tal Tirosh-Wagner;Alexander Eckehart Urban;Xiao Ning Chen

  • Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells.

    N Quintrell;R Lebo;H Varmus;J M Bishop

  • Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

    Meir Wetzler;Richard K. Dodge;Krzysztof Mrózek;Andrew J. Carroll

  • The human cornea has a high incidence of acquired chromosome abnormalities

    Mark J. Pettenati;Andrew J. Sweatt;Patrick Lantz;Constance A. Stanton

  • Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

    Sherif S. Farag;Kellie J. Archer;Krzysztof Mrózek;Amy S. Ruppert

  • Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461

    John C. Byrd;Amy S. Ruppert;Krzysztof Mrózek;Andrew J. Carroll

  • Identification of a Mutation in DLX3 Associated with Tricho-Dento-Osseous (TDO) Syndrome

    Jennifer A. Price;Donald W. Bowden;J. Tim Wright;Mark J. Pettenati

  • Down syndrome congenital heart disease: a narrowed region and a candidate gene.

    Gillian M. Barlow;Xiao Ning Chen;Zheng Y. Shi;Gary E. Lyons

  • Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

    Amy M. Hicks;Gregory Riedlinger;Mark C. Willingham;Martha A. Alexander-Miller

  • Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders

    M J Pettenati;M M Le Beau;R S Lemons;E A Shima

  • Molecular characterization of a third member of the guanylyl cyclase-activating protein subfamily.

    Françoise Haeseleer;Izabela Sokal;Ning Li;Ning Li;Mark Pettenati

  • Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2-year multi-center retrospective study and review of the literature.

    J. Tepperberg;M. J. Pettenati;P. N. Rao;C. M. Lese

  • Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study

    Sherif S. Farag;Amy S. Ruppert;Krzysztof Mrózek;Robert J. Mayer

  • The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

    R. A. Pierce;E. D. Field;T. Mutis;T. N. Golovina

  • The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis.

    Xiaohua Chen;H.A.Rohan de Silva;Mark J. Pettenati;P.Nagesh Rao

  • Genetic Linkage of Hereditary Gingival Fibromatosis to Chromosome 2p21

    Thomas C. Hart;Debora Pallos;Donald W. Bowden;Joey Bolyard

Frequent Co-Authors

Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Richard A. Larson
Richard A. Larson University of Chicago
Bayard L. Powell
Bayard L. Powell Wake Forest University
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Vandana Shashi
Vandana Shashi Duke University
Donald W. Bowden
Donald W. Bowden Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to a variety of advanced healthcare degrees and management roles. Many students pursue online programs for added flexibility, career advancement, and specialization. For example, if you are interested in healthcare leadership, consider online mha programs cahme accredited for a credential that is widely respected among employers.

Those looking to make an impact in nursing can benefit from online dnp programs without clinicals, which allow you to advance your expertise with fewer hands-on requirements. If your focus is on research or academic leadership, a phd in healthcare administration online can be a great option.

For those with a background in biochemistry or pharmacology, advancing in the field is possible through online pharmd programs. These pathways reflect the diversity of career opportunities available to Biology and Biochemistry graduates, whether you are aiming for clinical practice, management, or research.

Best Scientists Citing Mark J. Pettenati

Trending Scientists

Recently Published Articles